Stoke Therapeutics Inc buy Needham & Company LLC
Start price
08.03.23
/
50%
€8.60
Target price
08.03.24
€23.71
Performance (%)
-20.93%
End price
09.03.24
€6.80
Summary
This prediction ended on 09.03.24 with a price of €6.80. The prediction for Stoke Therapeutics Inc disappointed with a performance of -20.93%. Needham___Company_LL has a follow-up prediction for Stoke Therapeutics Inc where he still thinks Stoke Therapeutics Inc is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Stoke Therapeutics Inc | 4.717% | 4.717% | - |
iShares Core DAX® | -1.370% | -3.231% | 11.661% |
iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% |
iShares Nikkei 225® | -0.801% | -7.859% | 18.597% |
iShares S&P 500 | -0.369% | -2.979% | 26.341% |
Comments by Needham___Company_LL for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $25.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Current prediction by Needham___Company_LL for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€5.20
07.08.23
07.08.23
€22.72
07.08.24
07.08.24
109.62%
29.04.24
29.04.24
Stopped prediction by Needham___Company_LL for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€12.00
11.04.24
11.04.24
€20.48
11.04.25
11.04.25
-14.17%
29.04.24
29.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€9.30
26.03.24
26.03.24
€20.27
26.03.25
26.03.25
17.20%
29.04.24
29.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€4.86
16.02.24
16.02.24
€13.02
16.02.25
16.02.25
111.93%
29.04.24
29.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€4.46
07.11.23
07.11.23
€13.09
07.11.24
07.11.24
144.39%
29.04.24
29.04.24